DVR Pharma LLP
About DVR Pharma LLP
Data last updated:
DVR Pharma LLP is a limited liability partnership (LLP) based in Nalgonda, Telangana, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 20 August 2016 and has been in existence for over 10 years.
The LLP is registered with the Registrar of Companies (ROC), Hyderabad, under LLPIN AAH-1892. Its GSTIN is 36AAMFD6269N2ZN (Telangana). The LLP holds 2 GST registrations, of which 1 is active.
The LLP has a total obligation of contribution of ₹20 Lakh. It is led by designated partners including Prabhakar Damannagari and Sujan Reddy Gurudu.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Sy. No. 158 & 159 Pedda Parvathapur Rangapur Village Bommala Ramaram, Nalgonda, Telangana, India – 508126.
As per the financials filed for FY 2021, the LLP reported a revenue of ₹15.2 Cr, a growth of 94% compared to the previous year. For the same year it recorded EBITDA of ₹1.22 Cr (EBITDA margin 8%). Revenue has grown at a compounded annual rate (CAGR) of 59% over three years.
The LLP has about 22 employees on its provident fund (EPFO) records.
The LLP is associated with 1 brand: DVR Pharma. As per MCA filings, the LLP has open charges of ₹6.91 Cr and satisfied charges of ₹10.06 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressSy. No. 158 & 159 Pedda Parvathapur Rangapur Village Bommala Ramaram, Nalgonda, Telangana, India – 508126
- IndustryChemicals and Materials, Industrial Chemicals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of DVR Pharma LLP FY 2025 filings available
DVR Pharma LLP reported revenue of ₹15.2 Cr (up 94% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR) of DVR Pharma LLP
Revenue has grown at a compounded annual rate (CAGR) of 59% over three years, including 94% growth in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of DVR Pharma LLP
| Statement of Account and Solvency | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | ₹15.2 Cr | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of DVR Pharma LLP
| Statement of Account and Solvency | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of DVR Pharma are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of DVR Pharma LLP
DVR Pharma has 4 current designated partners and 2 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prabhakar Damannagari | Partner | 19 Nov 2025 | 0 Years 10 Months | Current |
| Sujan Reddy Gurudu Also directs: Kylan Pharmaceuticals Private Limited, Vibha Projects LLP, KVB Asta Life Sciences Private Limited and 1 more | Partner | 19 Nov 2025 | 0 Years 10 Months | Current |
| Dilip Kumar Reddy Dagada | Designated Partner | 20 Aug 2016 | 10 Years 1 Months | Current |
| Shashidhar Reddy Kandadi | Designated Partner | 19 Nov 2025 | 0 Years 10 Months | Current |
Ownership and Shareholding of DVR Pharma LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of DVR Pharma LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Jun 2025 | Hdfc Bank Limited | ₹16.07 Lakh | Open |
| 08 Jul 2024 | Hdfc Bank Limited | ₹6.75 Cr | Open |
| 15 Feb 2022 | The Karur Vysya Bank Limited | ₹46 Lakh | Satisfied |
| 08 Jun 2020 | The Karur Vysya Bank Limited | ₹50 Lakh | Satisfied |
| 06 Oct 2018 | Karur Vysya Bank | ₹2.5 Cr | Satisfied |
Total charge records: 6 View all charges
Associated Brands with DVR Pharma LLP
DVR Pharma operates one associated brand: DVR Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| DVR Pharma manufactures and exports APIs and intermediates for the pharmaceutical industry. | dvrpharma.com |
Employees and EPFO Compliance at DVR Pharma LLP
DVR Pharma LLP has a workforce of 22 employees as of Oct 23, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on DVR Pharma LLP
DVR Pharma LLP has 6 designated partner changes on record since 2016: 4 appointments and 2 cessations. The latest: Manugunta Sasya Reddy ceased to be Designated Partner on 19 Nov 2025.
9 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for DVR Pharma LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by DVR Pharma LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of DVR Pharma LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of DVR Pharma LLP
DVR Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAMFD6269N2ZN | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of DVR Pharma LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DVR Pharma LLP
DVR Pharma is an active limited liability partnership based in Nalgonda, Telangana, India. The LLP works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 20 August 2016 (10+ years old) and is registered under LLPIN AAH-1892.
DVR Pharma reported revenue of ₹15.2 Cr for FY 2021 (up 94% YoY).
DVR Pharma has 4 current designated partners:
- Prabhakar Damannagari - Partner
- Sujan Reddy Gurudu - Partner
- Dilip Kumar Reddy Dagada - Designated Partner
- Shashidhar Reddy Kandadi - Designated Partner
DVR Pharma reported EBITDA of ₹1.22 Cr (EBITDA margin 8%) for FY 2021, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of DVR Pharma is 59% over three years. In the latest year (FY 2021) revenue rose 94%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of DVR Pharma is 36AAMFD6269N2ZN, registered in Telangana. The LLP has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The LLPIN (Limited Liability Partnership Identification Number) of DVR Pharma is AAH-1892. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
DVR Pharma was incorporated on 20 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.
Manugunta Sasya Reddy ceased to be Designated Partner on 19 Nov 2025. Prabhakar Damannagari was appointed as Partner on 19 Nov 2025. Shashidhar Reddy Kandadi was appointed as Designated Partner on 19 Nov 2025. DVR Pharma has 6 designated partner changes on record in total.
The registered office of DVR Pharma is at Sy. No. 158 & 159 Pedda Parvathapur Rangapur Village Bommala Ramaram, Nalgonda, Telangana, India – 508126.